Ausgabe 9/2013
Inhalt (7 Artikel)
Clinical Pharmacology of Axitinib
Ying Chen, Michael A. Tortorici, May Garrett, Brian Hee, Karen J. Klamerus, Yazdi K. Pithavala
Ginkgo biloba Extracts: A Review of the Pharmacokinetics of the Active Ingredients
Christian Ude, Manfred Schubert-Zsilavecz, Mario Wurglics
Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
Ken Ogasawara, Shripad D. Chitnis, Reginald Y. Gohh, Uwe Christians, Fatemeh Akhlaghi
A Semiphysiological Population Pharmacokinetic Model for Dynamic Inhibition of Liver and Gut Wall Cytochrome P450 3A by Voriconazole
Sebastian Frechen, Lisa Junge, Teijo I. Saari, Ahmed Abbas Suleiman, Dennis Rokitta, Pertti J. Neuvonen, Klaus T. Olkkola, Uwe Fuhr
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke, Manfred Schuster, Marko Poglitsch, Hans Loibner, Marc Salzberg, Marcel Bruggisser, Joseph Penninger, Stephan Krähenbühl
Pharmacokinetic–Pharmacodynamic Modeling of the Antihypertensive Effect of Eprosartan in Black and White Hypertensive Patients
Petra C. van Rijn-Bikker, Oliver Ackaert, Nelleke Snelder, Reinier M. van Hest, Bart A. Ploeger, Richard P. Koopmans, Ron A. A. Mathôt
Pharmacokinetics of a Three-Way Drug Interaction Between Danoprevir, Ritonavir and the Organic Anion Transporting Polypeptide (OATP) Inhibitor Ciclosporin
Barbara J. Brennan, Sebastian A. Moreira, Peter N. Morcos, Mercidita T. Navarro, Jiney Asthappan, Petra Goelzer, Paul Weigl, Patrick F. Smith